Powder: -20°C for 3 years | In solvent: -80°C for 1 year
C13-112-tetra-tail, a cationic lipid-like compound, features a polar amino alcohol head group, four hydrophobic C13 tails, and a PEG2 linker, making it suitable for formulation into lipid nanoparticles (LNPs).
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | 35 days | $ 63.00 | |
5 mg | 35 days | $ 235.00 | |
10 mg | 35 days | $ 313.00 |
Description | C13-112-tetra-tail, a cationic lipid-like compound, features a polar amino alcohol head group, four hydrophobic C13 tails, and a PEG2 linker, making it suitable for formulation into lipid nanoparticles (LNPs). |
Molecular Weight | 941.58 |
Formula | C58H120N2O6 |
CAS No. | 1381861-92-2 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
C13-112-tetra-tail 1381861-92-2 inhibitor inhibit